Education and connection, putting faces to the names of patients, will go a long way in increasing the numbers in the registry, which will, in turn, increase the number of survivors.
(PRWEB) September 29, 2016
Every hour, 6 people in the U.S. die from a blood cancer. Against these odds, many patients take a blood cancer diagnosis as a death sentence. But hope is in sight. With innovative technologies and incredible leaders pulling together to fund research and clinical trials, there have been revolutionary results in the area of targeted cell treatments and immunotherapy. Researchers aren’t the only ones who can help increase survival rates; signing up to be a blood and bone marrow donor is a way that everyone can help to save lives.
Mia Hamm, Olympic Athlete and celebrity advocate for blood and bone marrow donation, graces the cover of the print campaign. Stressing the need for more donors to register at the National Bone Marrow Registry, Mia says, “Education and connection, putting faces to the names of patients, will go a long way in increasing the numbers in the registry, which will, in turn, increase the number of survivors.”
The print component of “Blood Cancer Awareness” is distributed within the Thursday, September 29 regional circulation of USA Today, with a circulation of approximately 450,000 copies and an estimated readership of 1.3 million within the New York, Los Angeles, Minneapolis, Chicago, DC/Baltimore, Denver, Seattle, Boston, Philadelphia and Houston markets. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, click here.
This edition of “Blood Cancer Awareness” was made possible with the support of the American Society of Hematology, the Leukemia and Lymphoma Society, Multiple Myeloma Research Foundation, Lymphoma Research Foundation, Aplastic Anemia and MDS International Foundation, Olympic Athlete Mia Hamm, AMGEN, Incyte Corporation, Agios, Asuragen, Adaptive Biotechnologies, DKMS, Epizyme, Fred Hutchinson Cancer Research Center, Imedex, Jazz Pharmaceuticals, Sarah Cannon Research Institute, Sysmex, Takeda Oncology, The Binding Site and many more.
About Mediaplanet
Mediaplanet is the leading independent publisher of content-marketing campaigns covering a variety of topics and industries. We turn consumer interest into action by providing readers with motivational editorial, pairing it with relevant advertisers and distributing it within top newspapers and online platforms around the world.